Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Patrick's Penny Players' Paradise -- Ignore unavailable to you. Want to Upgrade?

To: paul s. who wrote (23)	7/9/1998 11:10:00 PM
From: Warlock	Read Replies (1) \| Respond to of 275

1) Didn't get in on SCMI today. 2) PWLS. . . I'll paste the thread summary below (not mine). Spread is hefty, but with a small 1,000,000 share float, it moves very quickly. The company looks very solid, and I've spoken with Timothy Miles (heading financing, dealmaking, and PR for the company). It looks like some major promotional work is about to commence. Won't take much buying to move the stock. I was also faxed a copy of a sheet that is about to go out to a multitude of brokers. It is a risky play however. . . "Notice should be taken of BioNet Technologies. They have just announced their second acquisition and seem poised to take off. After a year and a half spent on reorgainzing the company with trading in the $.20 to $.50 range they are back on track as a multidivisional biotech company with a focus on consolidation. BioNet itself is run by a seasoned veteran with NYSE CEO experience and both acquisitions are loaded with credible individuals. I suggest you take the time to check this one out. Their first acquisition, Immune Technologies has proprietary products resulting from "immune modulation technology" with a focus on the veterinary side of the business. The veterinary focus is to achieve early cash flow. I applaud this move. The newest candidate "The Greengold Corporation" is headed up by "the worlds formost authority on duckweed production" and has patented technology which will, according to the company, have a huge impact on the animal waste problem globally as well as producing healthy cashflow in the process. I made a few calls and this one seems loaded with potential. I understand BioNet is working on implementing a financial PR program for the first time in its history as well. Sounds like the perfect opportunity to me. With just over 5 Million outstanding and 1 million in the float, we should see some significant short term gains as the investing public discovers this baby conglomerate with good long term prospects as well as the company continues to build its stable of acquisitions. I see this as a steal under $1 and a value to $2 once the second acquisition closes. I have started this thread under "PWLS - BioNet Technologies" as well. We will see which one takes off. Take your pick."